• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

破骨细胞直接影响去势抵抗性前列腺癌细胞。

Osteoclasts directly influence castration-resistant prostate cancer cells.

机构信息

Department of Urology, Institute of Clinical Sciences, Sahlgrenska Center for Cancer Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Department of Cell and Molecular Biology, Science for Life Laboratory, National Bioinformatics Infrastructure Sweden, Uppsala University, 75124, Uppsala, Sweden.

出版信息

Clin Exp Metastasis. 2022 Oct;39(5):801-814. doi: 10.1007/s10585-022-10179-2. Epub 2022 Aug 16.

DOI:10.1007/s10585-022-10179-2
PMID:35971022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9474581/
Abstract

Metastasis to bone is the leading cause of death from prostate cancer. Interaction between tumor cells and bone cells can promote progression and influence tumor phenotype. It is known that prostate cancer cells support osteoclast differentiation, and degradation of bone matrix by osteoclasts releases growth factors stimulating tumor cell proliferation and invasion. In the present study osteolytic (PC-3) and osteoblastic (LNCaP-19) castration-resistant prostate cancer (CRPC) cells were co-cultured with mature osteoclasts or their precursor cells (RAW 264.7) to characterize direct effects of mature osteoclasts on CRPC cells. Osteoclasts increased proliferation and decrease apoptosis of CRPC cells as assessed with flow cytometry. RNA sequencing revealed that osteolytic CRPC cells were more responsive to osteoclast stimulation regarding gene expression, but the overall induced expression patterns were similar between the prostate cancer cell lines. Genes related to DNA repair were upregulated by osteoclasts, while genes related to endoplasmic reticulum stress-induced apoptosis and cholesterol synthesis were downregulated. The results of this study shows that osteoclasts directly influence CRPC cells, increasing proliferation, decreasing apoptosis, and affecting gene expression pathways that can affect sensitivity to DNA damage and endoplasmic reticulum function. This suggests targeting of osteoclasts to be a possible way to affect efficacy of other drugs by combination regimens in treating prostate cancer metastases.

摘要

转移到骨骼是导致前列腺癌死亡的主要原因。肿瘤细胞与骨细胞之间的相互作用可以促进肿瘤的进展并影响肿瘤表型。已知前列腺癌细胞支持破骨细胞的分化,而破骨细胞对骨基质的降解释放出刺激肿瘤细胞增殖和侵袭的生长因子。在本研究中,溶骨性(PC-3)和成骨性(LNCaP-19)去势抵抗性前列腺癌(CRPC)细胞与成熟破骨细胞或其前体细胞(RAW 264.7)共培养,以表征成熟破骨细胞对 CRPC 细胞的直接影响。通过流式细胞术评估,破骨细胞增加了 CRPC 细胞的增殖并减少了细胞凋亡。RNA 测序表明,溶骨性 CRPC 细胞对破骨细胞刺激的基因表达更敏感,但两条前列腺癌细胞系之间的总体诱导表达模式相似。破骨细胞上调了与 DNA 修复相关的基因,而下调了与内质网应激诱导的细胞凋亡和胆固醇合成相关的基因。本研究的结果表明,破骨细胞直接影响 CRPC 细胞,增加增殖,减少凋亡,并影响可能影响 DNA 损伤和内质网功能敏感性的基因表达途径。这表明通过联合治疗方案靶向破骨细胞可能是影响治疗前列腺癌转移的其他药物疗效的一种方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c5f/9474581/578d5664744b/10585_2022_10179_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c5f/9474581/f83d224b4cd7/10585_2022_10179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c5f/9474581/9f98896312f3/10585_2022_10179_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c5f/9474581/b3c169ef2a58/10585_2022_10179_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c5f/9474581/578d5664744b/10585_2022_10179_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c5f/9474581/f83d224b4cd7/10585_2022_10179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c5f/9474581/9f98896312f3/10585_2022_10179_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c5f/9474581/b3c169ef2a58/10585_2022_10179_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c5f/9474581/578d5664744b/10585_2022_10179_Fig4_HTML.jpg

相似文献

1
Osteoclasts directly influence castration-resistant prostate cancer cells.破骨细胞直接影响去势抵抗性前列腺癌细胞。
Clin Exp Metastasis. 2022 Oct;39(5):801-814. doi: 10.1007/s10585-022-10179-2. Epub 2022 Aug 16.
2
The roles of RUNX2 and osteoclasts in regulating expression of steroidogenic enzymes in castration-resistant prostate cancer cells.RUNX2 和破骨细胞在调节去势抵抗性前列腺癌细胞类固醇生成酶表达中的作用。
Mol Cell Endocrinol. 2021 Sep 15;535:111380. doi: 10.1016/j.mce.2021.111380. Epub 2021 Jul 1.
3
Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3.白皮杉醇酸,一种天然三萜烯,通过激活 IRE-1/JNK、PERK/CHOP 和 TRIB3,引起去势抵抗性前列腺癌细胞中依赖内质网应激的细胞凋亡。
J Exp Clin Cancer Res. 2018 Sep 3;37(1):210. doi: 10.1186/s13046-018-0889-x.
4
Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis.成骨细胞通过改变肿瘤内的类固醇生成促进去势抵抗性前列腺癌。
Mol Cell Endocrinol. 2016 Feb 15;422:182-191. doi: 10.1016/j.mce.2015.11.013. Epub 2015 Nov 14.
5
Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies.成骨细胞在体外和体内研究的新型模型中刺激去势抵抗性前列腺癌的成骨和转移进展。
Clin Exp Metastasis. 2014 Mar;31(3):269-83. doi: 10.1007/s10585-013-9626-1. Epub 2013 Dec 1.
6
Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.患者来源的激素敏感型前列腺癌异种移植模型揭示生长因子受体结合蛋白 10 作为雄激素受体抑制基因,驱动去势抵抗性前列腺癌的发展。
Eur Urol. 2018 Jun;73(6):949-960. doi: 10.1016/j.eururo.2018.02.019. Epub 2018 Mar 12.
7
Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.使用OGX - 427抑制热休克蛋白27可诱导内质网应激,并增强热休克蛋白90抑制剂对去势抵抗性前列腺癌的延缓作用。
Eur Urol. 2014 Jul;66(1):145-55. doi: 10.1016/j.eururo.2013.12.019. Epub 2013 Dec 29.
8
Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model.抗雄激素治疗在小鼠模型中诱导转移性去势抵抗性前列腺癌的转录组重编程。
Biochim Biophys Acta Mol Basis Dis. 2021 Jul 1;1867(7):166151. doi: 10.1016/j.bbadis.2021.166151. Epub 2021 Apr 21.
9
YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells.YAP与去势抵抗性前列腺癌密切相关,YAP的下调可降低PC-3细胞的增殖并诱导其凋亡。
Mol Med Rep. 2015 Oct;12(4):4867-76. doi: 10.3892/mmr.2015.4005. Epub 2015 Jun 29.
10
lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.长链非编码RNA HOXD-AS1通过招募WDR5调控去势抵抗性前列腺癌的增殖和化疗耐药性。
Mol Ther. 2017 Aug 2;25(8):1959-1973. doi: 10.1016/j.ymthe.2017.04.016. Epub 2017 May 6.

引用本文的文献

1
Drug Utilisation of Radium-223 Under Routine Clinical Practice (DIRECT) in Europe: A Post-Authorisation Safety Study.欧洲常规临床实践中镭-223的药物利用情况(DIRECT):一项上市后安全性研究。
Oncol Ther. 2025 Jun 16. doi: 10.1007/s40487-025-00344-4.
2
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer.转移性去势抵抗性前列腺癌中转移模式的改变与循环肿瘤DNA的动态变化相关。
Oncologist. 2025 May 8;30(5). doi: 10.1093/oncolo/oyaf107.
3
Role of Chemokines and Cytokines in Prostate Cancer Skeletal Metastasis.

本文引用的文献

1
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer.聚(ADP - 核糖)聚合酶(PARP)抑制:前列腺癌患者的一种新治疗途径
Drugs. 2022 May;82(7):719-733. doi: 10.1007/s40265-022-01703-5. Epub 2022 May 5.
2
Cholesterol and saturated fatty acids synergistically promote the malignant progression of prostate cancer.胆固醇和饱和脂肪酸协同促进前列腺癌的恶性进展。
Neoplasia. 2022 Feb;24(2):86-97. doi: 10.1016/j.neo.2021.11.004. Epub 2021 Dec 23.
3
Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C.
趋化因子和细胞因子在前列腺癌骨转移中的作用。
Curr Osteoporos Rep. 2024 Nov 25;23(1):3. doi: 10.1007/s11914-024-00897-9.
4
Research progress of bone metastases: From disease recognition to clinical practice.骨转移的研究进展:从疾病认知到临床实践
Front Oncol. 2023 Jan 25;12:1105745. doi: 10.3389/fonc.2022.1105745. eCollection 2022.
基于转录组的前列腺癌转移亚型 MetA-C 的临床和生物学相关性。
Mol Oncol. 2022 Feb;16(4):846-859. doi: 10.1002/1878-0261.13158. Epub 2021 Dec 27.
4
Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells.破骨细胞向具有骨保护和肿瘤抑制作用细胞的转化。
Cancers (Basel). 2021 Nov 9;13(22):5593. doi: 10.3390/cancers13225593.
5
Glutamine and Cholesterol Plasma Levels and Clinical Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Taxanes.谷氨酰胺和胆固醇血浆水平与接受紫杉烷类治疗的转移性去势抵抗性前列腺癌患者的临床结局
Cancers (Basel). 2021 Oct 1;13(19):4960. doi: 10.3390/cancers13194960.
6
SQLE Mediates Metabolic Reprogramming to Promote LN Metastasis in Castration-Resistant Prostate Cancer.SQLE介导代谢重编程以促进去势抵抗性前列腺癌的淋巴结转移。
Onco Targets Ther. 2021 Jul 24;14:4285-4295. doi: 10.2147/OTT.S315813. eCollection 2021.
7
The roles of RUNX2 and osteoclasts in regulating expression of steroidogenic enzymes in castration-resistant prostate cancer cells.RUNX2 和破骨细胞在调节去势抵抗性前列腺癌细胞类固醇生成酶表达中的作用。
Mol Cell Endocrinol. 2021 Sep 15;535:111380. doi: 10.1016/j.mce.2021.111380. Epub 2021 Jul 1.
8
Role of LncRNAs and CircRNAs in Bone Metabolism and Osteoporosis.长链非编码RNA和环状RNA在骨代谢与骨质疏松症中的作用
Front Genet. 2020 Nov 13;11:584118. doi: 10.3389/fgene.2020.584118. eCollection 2020.
9
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.双膦酸盐或 RANK 配体抑制剂治疗前列腺癌伴骨转移的男性患者:一项网状荟萃分析。
Cochrane Database Syst Rev. 2020 Dec 3;12(12):CD013020. doi: 10.1002/14651858.CD013020.pub2.
10
miRNAs in osteoclast biology.破骨细胞生物学中的微小RNA
Bone. 2021 Feb;143:115757. doi: 10.1016/j.bone.2020.115757. Epub 2020 Nov 17.